ALK amplification also underlies resistance to ALK TKIs (57) although it may not benefit tumor cells as it can trigger oncogenic stress and induce DNA damage especially upon discontinuation of an ALK TKI, resulting in tumor cell apoptosis and restoration of sensitivity to the inhibitor (85). This evidence concerns the gene ALK and neoplasm.